• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Does it seem odd to anyone that the Q2 earnings call is mandatory?

Wow! Let go in August 2015 RIF; so glad now! Best thing that ever happened to me. Took home a lot more coin than that.sucks for all effected but belove me; Grass Is Greener! Good Luck

Exact ditto to the above post. Except I got the call August 2014 in the very first round. It was the beginning of a new, much better, life!